在接受标准治疗剂量普雷加巴林的患者手术后的急性戒断
相关实验视频
Updated: Jul 25, 2025

07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
48.3K
Caitlin E Kulig1,2, Zamaan Hooda1, Elissa Lebow1
1St. Joseph's University Medical Center, Paterson, NJ, USA.
Journal of surgical case reports
|June 30, 2023
概括
本病例报告详细介绍了接受心脏手术的患者急性普雷加巴林戒断症状. 这突出了潜在的风险,即使在术后治疗剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 麻醉学 麻醉学
背景情况:
- 普雷加巴林是一种胺黄油酸类似物,通过抑制激发性神经递质释放来调节中枢神经系统的活动.
- 它被处方用于神经病痛状况,如 postherpetic 神经痛和糖尿病外围神经病变.
- 在非阿片类药物疼痛管理策略中,包括外科外科设置中,Pregabalin的使用正在增加.
研究的目的:
- 在外科手术期间报告患者出现急性普雷加巴林戒断症状的情况.
- 为了研究手术患者在治疗性普雷加巴林剂量下可能出现戒断症状的可能性.
主要方法:
- 病例报告详细介绍患者的经历.
- 在心脏手术后临床观察戒断症状.
主要成果:
- 患者在冠状动脉旁路和大动脉根扩大手术后表现出急性戒断症状.
- 尽管患者服用治疗水平的普雷加巴林,但这些症状仍然发生.
结论:
- 在外科手术期间,即使在治疗剂量下,也可能发生急性取消普雷加巴林.
- 这一案例强调了在手术患者中停止服用普雷加巴林时需要保持警.
- 需要进一步的研究,以了解不同患者群体中普雷加巴林的戒断特征.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
215
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
215
Desensitization and Tachyphylaxis
1.9K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.9K
Analgesia and Pain Management
665
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
665
Local Anesthetics: Adverse Effects
455
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
455
Local Anesthetics: Clinical Application as Epidural Anesthesia
458
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
458
Opioid Analgesics: Synthetic and Semisynthetic Opioids
346
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
346

